Association of fibrinogen and fibrinogen gene β148 and β854 polymorphisms with coronary heart disease

Cardiology

Volumn 111, Issue 3, 2008, Pages 167-170

  Sun, Ai Jun ^a   Ma, Hui Li ^a,e   Chen, Xue Ying ^a   Wang, Ying ^b   Fang, Ye Ming ^c   Ma, Yong Li ^d   Wang, Ke Qiang ^a   Zou, Yun Zeng ^a,b   Huang, Wei ^b   Ge, Jun Bo ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d Epidemic Prevention Brigade of Chengde City ^*  (China)

^e General Hospital of the Second Artillery   (China)

Author keywords

Coronary heart disease; Fibrinogen; Gene 148 854 polymorphism

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

AGED; CHINA; COHORT STUDIES; COMORBIDITY; CORONARY DISEASE; FEMALE; FIBRINOGEN; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEX DISTRIBUTION;

EID: 52949085765     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121599     Document Type: Article

References (20)

1. Vischetti M, Zito F, Benedetta Donati M, Iacoviello L: Analysis of gene environment interaction in coronary heart disease: fibrinogen polymorphisms as an example. Ital Heart J 2002;3:18-23.
2. Luc G, Bard J-M, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, et al: C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. Arteroscler Thromb Vasc Biol 2003;23:1255-1261.
3. Youngman LD, Keavney BD, Palmer A: Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls;test of causality by Mendelian randomization? Circulation 2000;102(suppl II):31-32.
4. Davey Smith G, Ebrahim S: 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
5. Ernst E, Resch KL: Fibrinogen as cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-963.
6. Humphries SE: The genetic contribution to the risk of thrombosis and cardiovascular disease. Trends Cardiovasc Med 1994;4:8217.
7. Humphries SE, Luong LA, Montgomery HE, Day IN, Mohamed Ali V, Yudkin JS: Gene-environment interaction in the determination of levels of plasma fibrinogen. Thromb Haemost 1999;82:818-825.
8. Mannila MN, Lovely RS, Kazmierczak SC, Eriksson P, Samnegård A, Farrell DH, Hamsten A, Silveira A: Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J Thromb Haemost 2007;4:766-773.
9. Blake GJ, Schmitz C, Lindpaintner K, Ridker PM: Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 2001;22:2262-2266.
10. Yu S, Sher B, Kudryk B, Redman CM: Fibrinogen precursors: order of assembly of fibrinogen chains. J Biol Chem 1984;259:10574-10581.
11. Ma H, Chen J: The association between βHae III polymorphisms located in the promoter region of βfibrinogen gene, plasma fibrinogen levels and coronary heart disease. Chin J Cardiol 1999;27:277-279.
12. Davey Smith G, Harbord R, Milton J: Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Arterioscler Thromb Vasc Biol 2005;25:2228-2233.
13. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, et al: Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J 2004;25:459-467.
14. Volzke H, Robinson DM, Kleine V, Hertwig S, Schwahn C, Grimm R, Eckel L, Rettig R: Preoperative plasma fibrinogen levels predict mortality after coronary artery bypass grafting. Thromb Haemost 2003;89:885-891.
15. Lee WH, Hwang TH, Oh GT, Kwon SU, Choi YH, Park JE: Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males. Vasc Med 2001;6:103-108.
16. Maghzal GJ, Brennan SO, George PM: Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans. Thromb Haemost 2003;90:1021-1028.
17. Folsom AR, Aleksic N, Ahn C, Boerwinkle E, Wu KK: β-Fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2001;11:166-170.
18. Leander K, Wiman B, Hallqvist J, Falk G, De Faire U: The G-455A polymorphism of the fibrinogen Bβ-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J Intern Med 2002;252:332-341.
19. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, et al: β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM Study. Circulation 1996;93:440-449.
20. Van't Hooft FM, von Bahr SJF, Silveira A, Iliadou A, Eriksson P, Hamsten A: Two common, functional polymorphisms in the promoter region of the β-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 1999;19:3063-3070.